8-K - Intercept Pharmaceuticals, Inc. | Modeledge

Intercept Pharmaceuticals, Inc.

Filing type: 8-K
Filing date: Nov 7, 2023
Updated: Nov 8, 2023 · 9:44 AM

Filing

8-KMaterial Contracts, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in

Exhibits

EX-3.1EXHIBIT 3.1 EX-3.2EXHIBIT 3.2 EX-4.1EXHIBIT 4.1 EX-4.2EXHIBIT 4.2 EX-99.1Material Contracts, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in EX-99.2Material Contracts, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in